CVS pharmacy was acquired by Accredo on December 2, 2018.
The acquisition will bring with it a huge opportunity to improve the patient experience and the healthcare landscape in the United States.
The new pharmacy will be the second of its kind to be acquired by the company, following the acquisition of Medivation, which acquired Bodega in January 2018.
Accredo is also working on acquiring other specialty pharmacies, including the leading specialty pharmacy chain, CVS Health, in a deal that is expected to close in the coming months.
It is unclear how many specialty pharmacy licenses will accrue to Accredo as it is not clear if it will be able to maintain a healthy inventory of specialty pharmacies.
The new Accredo specialty drugstore is expected have a combined inventory of nearly 40 million prescription medications, according to Accredico CEO and founder, James C. Korn.
Accredico has already opened more than 20 new specialty pharmacy locations in the past year, according the company.
“We are pleased to expand our existing presence and provide more opportunities for our patients in order to better meet their needs,” Korn said in a statement.
CVS and Accredico also announced they will launch an online pharmacy service for patients with pre-existing conditions in the next six months.
There are currently about 2,300 CVS pharmacies in the U.S., according to the company’s website.
Accredo’s website indicates that it will offer a wide range of specialty medications and health-care services.
For example, the company offers the following specialty medication types: Acetaminophen: Prescription and over-the-counter